Genomic DNA Methylation among Women in a Multiethnic New York City Birth Cohort

One plausible mechanism for the environment to alter cancer susceptibility is through DNA methylation. Alterations in DNA methylation can lead to genomic instability and altered gene transcription. Genomic DNA methylation levels have been inversely associated with age, suggesting that factors throughout life may be associated with declines in DNA methylation. Using information from a multiethnic New York City birth cohort (born between 1959 and 1963), we examined whether genomic DNA methylation, measured in peripheral blood mononuclear cells, was associated with smoking exposure and other epidemiologic risk factors across the life course. Information on prenatal and childhood exposures was collected prospectively through 1971, and information on adult exposures and blood specimens were collected in adulthood from 2001 to 2007. Methylation levels of leukocyte DNA were determined using a [3H]-methyl acceptance assay where higher values of disintegrations per minute per microgram DNA indicate less DNA methylation. Genomic methylation of leukocyte DNA differed by ethnicity (66% of Blacks, 48% of Whites, and 29% of Hispanics were above the median level of disintegrations per minute per microgram DNA; P = 0.03). In multivariable modeling, DNA methylation was statistically significantly associated with maternal smoking during pregnancy, longer birth length, later age at menarche, nulliparity, and later age at first birth. These data, if replicated in larger samples, suggest that risk factors across the life course may be associated with DNA methylation in adulthood. Larger studies and studies that measure within-individual changes in DNA methylation over time are a necessary next step. (Cancer Epidemiol Biomarkers Prev 2008;17(9):2306–10)

[1]  Debra Silverman,et al.  Genomic DNA hypomethylation as a biomarker for bladder cancer susceptibility in the Spanish Bladder Cancer Study: a case-control study. , 2008, The Lancet. Oncology.

[2]  J. Califano,et al.  DNA global hypomethylation in squamous cell head and neck cancer associated with smoking, alcohol consumption and stage , 2007, International journal of cancer.

[3]  V. Slavkovich,et al.  Genomic methylation of peripheral blood leukocyte DNA: influences of arsenic and folate in Bangladeshi adults. , 2007, The American journal of clinical nutrition.

[4]  E. Andres Houseman,et al.  Global DNA Methylation Level in Whole Blood as a Biomarker in Head and Neck Squamous Cell Carcinoma , 2007, Cancer Epidemiology Biomarkers & Prevention.

[5]  P. Molloy,et al.  DNA hypomethylation and human diseases. , 2007, Biochimica et biophysica acta.

[6]  S. Duthie,et al.  Sensitivity of markers of DNA stability and DNA repair activity to folate supplementation in healthy volunteers , 2006, British Journal of Cancer.

[7]  Kentaro Yamashita,et al.  Global DNA demethylation in gastrointestinal cancer is age dependent and precedes genomic damage. , 2006, Cancer cell.

[8]  T. Spector,et al.  Epigenetic differences arise during the lifetime of monozygotic twins. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[9]  Andrew P Feinberg,et al.  The epigenetics of cancer etiology. , 2004, Seminars in cancer biology.

[10]  M. Szyf,et al.  DNA methylation and breast cancer. , 2004, Biochemical pharmacology.

[11]  P. Guldberg,et al.  DNA methylation analysis techniques , 2004, Biogerontology.

[12]  D. Heimburger,et al.  Race- and age-dependent alterations in global methylation of DNA in squamous cell carcinoma of the lung (United States) , 2003, Cancer Causes & Control.

[13]  P. Laird Early detection: The power and the promise of DNA methylation markers , 2003, Nature Reviews Cancer.

[14]  J. Groopman,et al.  DNA Methylation as a Cancer‐Specific Biomarker , 2003 .

[15]  R. Hayes,et al.  Epidemiologic Considerations to Assess Altered DNA Methylation from Environmental Exposures in Cancer , 2003, Annals of the New York Academy of Sciences.

[16]  B. Tycko Genetic and Epigenetic Mosaicism in Cancer Precursor Tissues , 2003, Annals of the New York Academy of Sciences.

[17]  J. Groopman,et al.  DNA methylation as a cancer-specific biomarker: from molecules to populations. , 2003, Annals of the New York Academy of Sciences.

[18]  M. Ehrlich,et al.  DNA methylation in cancer: too much, but also too little , 2002, Oncogene.

[19]  Peter A. Jones,et al.  The fundamental role of epigenetic events in cancer , 2002, Nature Reviews Genetics.

[20]  G. Rampersaud,et al.  Genomic DNA methylation decreases in response to moderate folate depletion in elderly women. , 2000, The American journal of clinical nutrition.

[21]  E. Oakeley DNA methylation analysis: a review of current methodologies. , 1999, Pharmacology & therapeutics.

[22]  I. Pogribny,et al.  Moderate folate depletion increases plasma homocysteine and decreases lymphocyte DNA methylation in postmenopausal women. , 1998, The Journal of nutrition.

[23]  C. Wagner,et al.  DNA methylation in folate deficiency: use of CpG methylase. , 1993, Biochemical and biophysical research communications.

[24]  A. Feinberg,et al.  Hypomethylation distinguishes genes of some human cancers from their normal counterparts , 1983, Nature.